Vanderbilt University


Vanderbilt Rapidly Accelerates Research Deal Making Targeting COVID-19 Including Access to Open-Source Research Opportunity

Vanderbilt researchers have pivoted a great deal of research activity toward addressing the COVID-19 pandemic. Vanderbilt’s Center for Technology Transfer & Commercialization (CTTC) has accelerated its services to facilitate three option/license agreements, 43...

Vanderbilt’s Warren Center Inks CNS-based Drug Development Deal with ACADIA Pharmaceuticals Showcasing their “De-Risking” Model

In an effort to develop and commercialize central nervous system disorder therapies, such as Alzheimer’s disease and schizophrenia, Vanderbilt University’s Warren Center for Neuroscience Drug Discovery (VCNDD) entered into an exclusive worldwide licensing and...

Pin It on Pinterest